Daily Aspirin May Reduce Cancer Risk
“Daily Aspirin may reduce cancer risk, bBut the high dose needed brings its own dangers, experts warn”, says an article from HealthDay News.
A daily aspirin may lower the odds of colon, prostate and breast cancer for people at high risk for those malignancies, researchers at the American Cancer Society report.
The researchers found that taking daily aspirin for at least five years was linked with about a 15 percent relative reduction in overall cancer risk. This decrease did not reach statistical significance in women, however.
In addition, aspirin was associated with a 20 percent reduction in the risk of prostate cancer and a 30 percent reduction in the risk of colorectal cancer in both men and women, compared with people who didn’t take the medicine, Jacobs’s team found.
Aspirin had no effect on risk of lung cancer, bladder cancer, melanoma, leukemia, non-Hodgkin’s lymphoma, pancreatic cancer, and kidney cancer, the researchers noted. Also, aspirin use for less than five years did not lower the risk for cancer.
However, the researchers still has to give recommendations for Aspirin therapy for cancer. The toxicities of aspirin intake are still major concerns for recommendation of this “new” therapy, thus, it was advised that patients should not take the drug for prevention of cancer as of this moment. Further studies are needed to prove these latest findings.
